Nephroprotective effect of HZF by upregulating IκBα protein expression in DKD mice

Shengnan Lv; Ning Qiao; Yuxuan Song; Yanjun Wang; Linghuan Gao

doi:10.62051/ijphmr.v1n1.14

Authors

Shengnan Lv
Ning Qiao
Yuxuan Song
Yanjun Wang
Linghuan Gao

DOI:

https://doi.org/10.62051/ijphmr.v1n1.14

Keywords:

Nephroprotective, HEZHIFANG, IκBα, Diabetes

Abstract

HEZHIFNAG (HZF) is a traditional Chinese prescription used to treat diabetes. In this study, a mouse model of diabetic kidney disease (DKD) induced by alloxan was used, and the random blood glucose of diabetic mice decreased significantly after the intervention of HZF, and the morphological results showed that HZF improved the pathological damage of glomeruli, reduced the degree of fibrosis of kidney tissue, and increased the expression level of IKBα in the kidney of diabetic mice, suggesting that HZF has a protective effect on the DKD mice, and the mechanism of action may be related to the up-regulation of IKB-α expression.

References

Zhou K, Wang S, Jin G, et.al. Mechanism of Renal Protection of Yishen Huashi Granules in db/db Mice through p38 MAPK Signaling Pathway. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 1-13. doi:10.13422/j.cnki.syfjx.20240340.

A/L B Vasanth Rao VR, Tan SH, Candasamy M, et al. Diabetic nephropathy: An update on pathogenesis and drug development. Diabetes Metab Syndr. 2019, 13(1):754-762. doi: 10.1016/j.dsx.2018.11.054. Epub 2018 Nov 30. PMID: 30641802.

Ren M, Wu Z, Gao F, et.al. Effects of Modified Shengjiang Powder on Renal Endoplasmic Reticulum Stress and Sirt1/PERK Pathway in Diabetes Nephropathy Rats. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 1-13. doi:10.13422/j.cnki.syfjx.20240340.

Zhou G, Cui J, Xie S, et al Vitexin, a fenugreek glycoside, ameliorated obesity-induced diabetic nephropathy via modulation of NF-κB/IkBα and AMPK/ACC pathways in mice. Biosci Biotechnol Biochem. 2021, 85(5):1183-1193. doi: 10.1093/bbb/zbab012. PMID: 33704405.

AlGeffari MA, Mansour D, Ahmed-Farid O, et al. Lactiplantibacillus plantarum and Saussurea costus as Therapeutic Agents against a Diabetic Rat Model-Approaches to Investigate Pharmacophore Modeling of Human IkB Kinase and Molecular Interaction with Dehydrocostus Lactone of Saussurea costus. Metabolites. 2023, 13(6):764. doi: 10.3390/metabo13060764. PMID: 37367922; PMCID: PMC10302201.

Geng H, Deng H, Wu Y, et al. Exploration of the academic thought of Chen Shiduo on thirst-quenching [J]. Chinese Folk Therapy, 2023, 31(14):15-18. DOI:10.19621/j.cnki.11-3555/r.2023.1405.

Liang WJ, Yang HW, Liu HN, et al. HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy. Life Sci. 2020 Jan 15; 241:117146. doi:10.1016/j.lfs.2019.117146.

Suzuki J, Ogawa M, Muto S, et al. Novel IkB kinase inhibitors for treatment of nuclear factor-kB-related diseases. Expert Opin Investig Drugs. 2011 Mar; 20(3):395-405. doi: 10.1517/13543784.2011.559162. PMID: 21314234.

Clarkson R. IkB kinase alpha: a link in the chain of the mammary cycle. Breast Cancer Res. 2002; 4(5):173-5. doi:10.1186/bcr446.

Jiang Y, Yang L, Yang X, et al. The imidazopyridine derivative X22 prevents diabetic kidney dysfunction through inactivating NF-κB signaling. Biochem Biophys Res Commun. 2020 May 14; 525(4):877-882. doi: 10.1016/j.bbrc.2020.03.016. Epub 2020 Mar 11. PMID: 32171523.

Luo LP, Suo P, Ren LL, et al. Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways. Front Pharmacol. 2021 Dec 22; 12:800522. doi:10.3389/fphar.2021.800522.